BPC
DGX icon

Banque Pictet & Cie’s Quest Diagnostics DGX Stock Holding History

Banque Pictet & Cie’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,148
Closed -$302K – 458
2023
Q2 		$302K Sell
2,148
-26,818
-93% -$3.7M ﹤0.01% 448
2023
Q1 		$4.1M Buy
28,966
+2,574
+10% +$368K 0.04% 193
2022
Q4 		$4.13M Buy
26,392
+2,496
+10% +$359K 0.04% 200
2022
Q3 		$2.93M Sell
23,896
-6,292
-21% -$829K 0.03% 236
2022
Q2 		$4.01M Sell
30,188
-3,138
-9% -$428K 0.04% 201
2022
Q1 		$4.56M Buy
33,326
+3,275
+11% +$456K 0.04% 198
2021
Q4 		$5.2M Buy
+30,051
New +$4.57M 0.04% 207

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Banque Pictet & Cie's DGX Position: Q3 2023 in Review

Banque Pictet & Cie sold out of Quest Diagnostics (DGX) in Q3 2023, closing a stake of 2,148 shares — an estimated $302K sold.

Banque Pictet & Cie first reported a position in DGX in Q4 2021 and held it in 7 quarters. The position peaked at $5.2M in Q4 2021. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

  • Banque Pictet & Cie reported no remaining Quest Diagnostics position as of Q3 2023 after selling out during the quarter.
  • Banque Pictet & Cie sold 2,148 Quest Diagnostics shares in Q3 2023, an estimated $302K.
  • Banque Pictet & Cie first reported a position in Quest Diagnostics in Q4 2021 and held it in 7 quarters.
  • Banque Pictet & Cie's Quest Diagnostics position peaked at $5.2M in Q4 2021.
  • 794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on Banque Pictet & Cie's 13F filing for Q3 2023, filed 2 Nov 2023.